Key result
Neonatal EKG screening is highly cost-effective and may permit early identification of SIDS risk.
Why the study?
Does neonatal electrocardiographic screening improve early identification of infants at risk for SIDS compared to routine neonatal examinations?
Does neonatal electrocardiographic screening improve early identification of infants at risk for SIDS compared to routine neonatal examinations?
Neonatal EKG screening in the first month of life is proposed as a cost-effective method to identify infants at risk for SIDS due to LQTS.
Neonatal ECG screening for SIDS risk should not yet change practice; leaves open need for prospective outcome trials.
Prolongation of the QT interval is the cause of about 10% cases of sudden infant death syndrome (SIDS) innewborns but it is also responsible for about 5% of sudden deaths in adults. LQTS is associated with life threateningarrhythmias such us torsade de pointes ventricular tachycardia or ventricular fibrillation (VF) leading to suddendeath.Congenital causes (channelopathies) of LQTS are associated to mutations with different hereditary patternaccording affected gene but it has been proven that several drugs and electrolytic alterations can significantlyincrease the QT interval. However, the cost-effectiveness of neonatal electrocardiographic (EKG) screening hasbeen questioned and despite studies made in newborns there is still no consensus about the best moment to makeand electrocardiographic screening.Previous studies demonstrate that newborns with QTc values over 470 msec often normalize by themselves inthe first month of life. However in some cases these values remain high after first months of life. These cases aremore frequently in determinate ethnics (Maghreb, Morocco and India-Pakistan). These races could be linked tocardiac electrical alterations with a hereditary pattern of variable penetrance. An EKG performed in the first month oflife will allow the early identification of still asymptomatic infants with LQTS and also infants with some correctablecongenital heart defects (CHD) not recognized by routine neonatal examinations. Appropriate therapy will preventunnecessary deaths in infants, children, and young adults. At the light of this literature review we could assess thatneonatal electrocardiographic screening is highly cost-effective and it may permit the early identification of infants atrisk for SIDS.
No takes yet. Share an insight, caveat, or question.
Torres F Garcia J (2015) conducted a review in Long-QT Syndrome. Neonatal electrocardiographic (EKG) screening was evaluated. Neonatal electrocardiographic screening is highly cost-effective and may permit the early identification of infants at risk for sudden infant death syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: